||Recombinant Human LRP4 (Accession # AAI36669) was produced in Chinese Hamster Ovary cell line, CHO-derived.
|Predicted N Terminal:
||Ser21 & Gly212
||Lyophilized from a 0.2 µm filtered solution in PBS.
||Measured by its binding ability in a functional ELISA.When Recombinant Human USAG1 is coated at 2 µg/mL, Recombinant Human LRP-4 binds with an apparent KD <1 nM.
||Recombinant Human LRP4 has a calculated MW of 191 kDa. In SDS-PAGE migrates as 180-225 kDa, reducing conditions.
||>80%, by SDS-PAGE under reducing conditions and visualized by silver stain.
||Avoid repeated freeze-thaw cycles. No activity loss was observed after storage at: In lyophilized state for 1 year (4ºC); After reconstitution under sterile conditions for 3 months (-70ºC).